Neuralstem Stock Price - CUR

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Neuralstem Inc CUR NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.05 3.85% 1.35 1.40 1.23 1.29 1.30 16:30:00
Bid Price Ask Price Spread Spread % News
1.30 1.38 0.08 5.8% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
437 101,489 $ 1.32 $ 134,005 68,994 1.10 - 24.20
Last Trade Time Type Quantity Stock Price Currency
16:00:00 300 $ 1.35 USD

Neuralstem Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.56M 2.64M $ -4.92M -6.43 - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 5.00 -

more financials information »

Neuralstem News

Loading Messages....

Latest CUR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CUR Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week1.351.41.11.2437103k0-
1 Month1.791.931.11.523893k-0.44-24.58%
3 Months4.756.251.12.2382103k-3.4-71.58%
6 Months1011.41.15.9617140k-8.65-86.50%
1 Year20.424.21.19.0102187k-19.05-93.38%
3 Years80.081321.144.7324356k-78.73-98.31%
5 Years431.6509.61.193.7795390k-430.25-99.69%

Neuralstem Description

Neuralstem Inc is a clinical-stage biopharmaceutical company. The company is engaged in research, development, and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. Its technology base has produced three primary assets: NSI-189 small molecule program, NSI-566 stem cell therapy program and novel and proprietary new chemical entity screening platform.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.